medigraphic.com
ISSN 2448-5640 (Impreso)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.

2025, Número 2

Siguiente >>

Cir Card Mex 2025; 10 (2)


Un estudio que no cambia el juego: el MATTERHORN y la confirmación de lo obvio en una población altamente selectiva

García-Villarreal OA, Rodríguez-Durán LE

Idioma: Ingles.
Referencias bibliográficas: 15
Paginas: 31-34
Archivo PDF: 672.20 Kb.





REFERENCIAS (EN ESTE ARTÍCULO)

  1. Baldus S, Doenst T, Pfister R, Gummert J, Kessler M, Boekstegers P, et al. Transcatheter Repair versus Mitral-Valve Surgery for Secondary Mitral Regurgitation. N Engl J Med. 2024;391(19):1787-1798. doi: 10.1056/NEJMoa2408739.

  2. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e35-e71. doi: 10.1161/CIR.0000000000000932.

  3. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561-632. doi: 10.1093/eurheartj/ehab395.

  4. Lancellotti P, Tribouilloy C, Hagendorff A, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2013;14(7):611-644. doi: 10.1093/ehjci/jet105.

  5. Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med. 2014;370(1):23-32. doi: 10.1056/NEJMoa1312808.

  6. Goldstein D, Moskowitz AJ, Gelijns AC, Ailawadi G, Parides MK, Perrault LP, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016;374(4):344-353. doi: 10.1056/NEJMoa1512913.

  7. Mihaljevic T, Lam BK, Rajeswaran J, Takagaki M, Lauer MS, Gillinov AM, et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol. 2007;49(22):2191-2201. doi: 10.1016/j.jacc.2007.02.043.

  8. Virk SA, Tian DH, Sriravindrarajah A, Dunn D, Wolfenden HD, Suri RM, et al. Mitral valve surgery and coronary artery bypass grafting for moderate-to-severe ischemic mitral regurgitation: Meta-analysis of clinical and echocardiographic outcomes. J Thorac Cardiovasc Surg. 2017;154(1):127-136. doi: 10.1016/j.jtcvs.2017.03.039.

  9. Yin L, Wang Z, Shen H, Min J, Ling X, Xi W. Coronary artery bypass grafting versus combined coronary artery bypass grafting and mitral valve repair in treating ischaemic mitral regurgitation: a meta-analysis. Heart Lung Circ. 2014;23(10):905-912. doi: 10.1016/j.hlc.2014.03.031.

  10. Edelman JJ, Thourani VH. Surgical management of severe FMR: what can COAPT and MITRA-FR teach us? American College of Cardiology. Latest in Cardiology. [Last Access: February 09, 2025] Available in: https://www.acc.org/latest-in-cardiology/articles/2019/10/28/11/09/surgical-management-of-severe-fmr

  11. Bakaeen FG, Gaudino M, Whitman G, et al; American Association for Thoracic Surgery Cardiac Clinical Practice Standards Committee; Invited Experts. 2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure. J Thorac Cardiovasc Surg. 2021;162(3):829-850.e1. doi: 10.1016/j.jtcvs.2021.04.052.

  12. Agricola E, Oppizzi M, Pisani M, Meris A, Maisano F, Margonato A. Ischemic mitral regurgitation: mechanisms and echocardiographic classification. Eur J Echocardiogr. 2008;9(2):207-221. doi: 10.1016/j.euje.2007.03.034.

  13. Farhan S, Silbiger JJ, Halperin JL, Zhang L, Dukkipati SR, Vogel B, et al. Pathophysiology, echocardiographic diagnosis, and treatment of atrial functional mitral regurgitation: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022;80(24):2314-2330. doi: 10.1016/j.jacc.2022.09.046.

  14. Asgar AW, Mack MJ, Stone GW. Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. J Am Coll Cardiol. 2015;65(12):1231-1248. doi: 10.1016/j.jacc.2015.02.009.

  15. Tymi?ska A, Oziera?ski K, Balsam P, Maciejewski C, Wancerz A, Brociek E, et al. Ischemic cardiomyopathy versus non-ischemic dilated cardiomyopathy in patients with reduced ejection fraction- clinical characteristics and prognosis depending on heart failure etiology (Data from European Society of Cardiology Heart Failure Registries). Biology (Basel). 2022;11(2):341. doi: 10.3390/biology11020341.




2020     |     www.medigraphic.com